Oregon Public Employees Retirement Fund’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,551
Closed -$118K 1671
2023
Q2
$118K Sell
4,551
-300
-6% -$8.03K ﹤0.01% 1664
2023
Q1
$139K Sell
4,851
-10
-0.2% -$298 ﹤0.01% 1646
2022
Q4
$144K Buy
4,861
+47
+1% +$1.34K ﹤0.01% 1638
2022
Q3
$115K Hold
4,814
﹤0.01% 1644
2022
Q2
$107K Sell
4,814
-700
-13% -$15.6K ﹤0.01% 1510
2022
Q1
$138K Sell
5,514
-100
-2% -$3.05K ﹤0.01% 1663
2021
Q4
$201K Sell
5,614
-200
-3% -$8.01K ﹤0.01% 1520
2021
Q3
$247K Hold
5,814
﹤0.01% 1491
2021
Q2
$252K Hold
5,814
﹤0.01% 1488
2021
Q1
$237K Buy
5,814
+100
+2% +$3.79K ﹤0.01% 1506
2020
Q4
$259K Sell
5,714
-89
-2% -$3.38K ﹤0.01% 1448
2020
Q3
$205K Hold
5,803
﹤0.01% 1410
2020
Q2
$219K Hold
5,803
﹤0.01% 1378
2020
Q1
$168K Buy
5,803
+300
+5% +$12.1K ﹤0.01% 1378
2019
Q4
$285K Sell
5,503
-200
-4% -$11.6K ﹤0.01% 1383
2019
Q3
$313K Buy
5,703
+100
+2% +$5.13K ﹤0.01% 1409
2019
Q2
$228K Buy
5,603
+100
+2% +$3.65K ﹤0.01% 1509
2019
Q1
$166K Buy
5,503
+99
+2% +$3.39K ﹤0.01% 1551
2018
Q4
$182K Buy
+5,404
New +$195K ﹤0.01% 1533

Other funds holding ANIK

Oregon Public Employees Retirement Fund's ANIK Position: Q3 2023 in Review

Oregon Public Employees Retirement Fund sold out of Anika Therapeutics (ANIK) in Q3 2023, closing a stake of 4,551 shares — an estimated $118K sold.

Oregon Public Employees Retirement Fund first reported a position in ANIK in Q4 2018 and held it in 19 quarters. The position peaked at $313K in Q3 2019. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • Oregon Public Employees Retirement Fund reported no remaining Anika Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 4,551 Anika Therapeutics shares in Q3 2023, an estimated $118K.
  • Oregon Public Employees Retirement Fund first reported a position in Anika Therapeutics in Q4 2018 and held it in 19 quarters.
  • Oregon Public Employees Retirement Fund's Anika Therapeutics position peaked at $313K in Q3 2019.
  • 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q3 2023, filed 27 Oct 2023.